Xencor Inc (XNCR)
NASDAQ:XNCR
Holding XNCR?
Track your performance easily

Xencor (XNCR) Income Statement

208 Followers

Xencor Income Statement

Last quarter (Q1 2024), Xencor's total revenue was $12.80M, a decrease of -32.61% from the same quarter last year. In Q1, Xencor's net income was $-68.03M. See Xencor’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 162.16M$ 168.34M$ 164.60M$ 275.10M$ 122.69M$ 156.70M
Cost of Revenue
------
Gross Profit
$ 162.10M$ 168.30M$ 164.60M$ 275.10M--
Operating Expense
$ 299.31M$ 306.98M$ 247.05M$ -231.34M$ 199.49M$ 142.88M
Operating Income
$ -137.15M$ -138.64M$ -82.47M$ 43.76M$ -76.80M$ 13.82M
Net Non Operating Interest Income Expense
$ 23.20M$ 18.63M$ 4.82M-$ 7.26M$ 13.62M
Other Income Expense
$ 17.74M$ 426.00K$ -17.71M$ -36.43M$ 200.00K$ -256.00K
Pretax Income
$ -131.70M$ -120.44M$ -54.51M$ 82.63M$ -69.33M$ 27.19M
Tax Provision
$ 5.81M$ 5.81M$ 673.00K$ -783.00K$ 0.00$ 312.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -132.10M$ -126.09M$ -60.60M$ 81.04M$ -69.33M$ 26.88M
Basic EPS
$ -2.19$ -2.08$ -0.93$ 1.42$ -1.21$ 0.48
Diluted EPS
$ -2.19$ -2.08$ -0.93$ 1.37$ -1.21$ 0.46
Basic Average Shares
$ 243.45M$ 60.50M$ 59.65M$ 58.38M$ 57.21M$ 56.53M
Diluted Average Shares
$ 243.45M$ 60.50M$ 59.65M$ 60.50M$ 57.21M$ 58.47M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 139.91M$ 306.98M$ 247.05M$ -231.34M$ 199.49M$ 142.88M
Net Income From Continuing And Discontinued Operation
$ -133.36M$ -126.09M$ -55.18M$ 81.04M$ -69.33M$ 26.88M
Normalized Income
$ -35.10M-$ -42.96M-$ -69.44M$ 26.88M
Interest Expense
------
EBIT
$ -111.07M$ -138.64M$ -59.33M$ 81.78M$ -76.80M$ 13.82M
EBITDA
$ -108.56M$ -127.14M$ -50.40M$ 92.43M$ -71.00M$ 18.12M
Currency in USD

Xencor Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis